Infectious Disease Management in Animal Shelters. Группа авторов
Respiratory Disease 13.7 Diagnostics 13.8 Treatment 13.9 Management and Prevention of URTD 13.10 Conclusion References
21 14 Canine Parvovirus and Other Canine Enteropathogens 14.1 Introduction 14.2 Canine Parvovirus‐2 14.3 Other Enteropathogens 14.4 Conclusion References
22 15 Feline Panleukopenia 15.1 Introduction 15.2 Epidemiology and Course of Disease 15.3 Clinical Signs 15.4 Morbidity/Mortality/Prognosis 15.5 Diagnosis 15.6 Treatment 15.7 Prevention and Control/Risk Assessment 15.8 Implications for Adoption and Foster Care 15.9 Conclusion References
23 16 Feline Coronavirus and Feline Infectious Peritonitis 16.1 Introduction 16.2 Etiology 16.3 Epidemiology 16.4 Pathogenesis 16.5 Transmission 16.6 Immune Response 16.7 Clinical Signs 16.8 Diagnosis 16.9 Treatment 16.10 Prevention and Control 16.11 Outbreak Management 16.12 Euthanasia Guidelines 16.13 Client Education/Implications for Adoption, Relocation and Foster Care 16.14 Conclusion References
24 17 Internal Parasites 17.1 Introduction 17.2 Parasite Transmission and Treatment Considerations in Animal Shelters 17.3 Parasites with Direct Transmission 17.4 Parasites with Indirect Transmission 17.5 Conclusion References
25 18 Heartworm Disease 18.1 Introduction 18.2 Lifecycle of Dirofilaria immitis 18.3 Transmission 18.4 Heartworm Disease in Dogs 18.5 Heartworm Disease in Cats 18.6 Heartworm Disease in Ferrets 18.7 Screening and Diagnostic Testing 18.8 Prevention 18.9 Heartworm Treatment 18.10 Conclusion References
26 19 External Parasites 19.1 Introduction 19.2 Ectoparasites with all Life Stages on the Host 19.3 Ectoparasites withEnvironmental and HostStages 19.4 Temporary Ectoparasites Associated with Hosts Only While Feeding 19.5 Conclusion 19.A Ectoparasites Potentially Affecting Shelter Animals References
27 20 Dermatophytosis 20.1 Introduction 20.2 Etiology 20.3 Pathogenesis 20.4 Disease Course 20.5 Transmission 20.6 Clinical Presentation and Differential Diagnoses 20.7 Diagnosis 20.8 Initial Risk Evaluation and Response 20.9 Treatment 20.9.1 Topical Treatment